Abstract
Trigeminal neuralgia (TGN) is a disorder characterized by brief but severe electric shock-like pain, which is abrupt in onset and termination, and is limited to the distribution of one or more divisions of the trigeminal nerve [1]. It is further sub-classified into classical (CTN) and symptomatic forms (STN), the latter is associated with a demonstrable lesion on imaging apart from a vascular loop [1]. STN should be suspected when a patient presents with bilateral symptoms or concomitant trigeminal sensory loss. The distinction is important as the treatment for both differs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
International Headache Society. The international classification of headache disorders: 2nd Edition. Cephalalgia. 2004;24(Suppl 1):9–160.
Obermann M. Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord. 2010;3:107–15.
Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265–7.
Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol. 1968;19:129–36.
Nicol CF. A four year double blind study of tegretol in facial pain. Headache. 1969;9:54–7.
Rockcliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1996;15:129–36.
Kutluay E, McCague K, D’Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4:175–80.
Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223–30.
Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–4.
Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22–7.
Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24:64–75.
Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28:174–81.
Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr. 2007;65:792–4.
Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16:740–4.
Desai N, Shah K, Gandhi I. Baclofen sodium valproate combination in carbamazepine resistant trigeminal neuralgia: a double blind clinical trial. Cephalalgia. 1991;II(Suppl):321–2.
Carasso RL, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci. 1979;9:191–4.
Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM, American Academy of Neurology Society, European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013–28.
William P. Cheshire. Trigeminal neuralgia: a guide to drug choice. CNS Drugs. 1997;7:98–110.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Agarwal, A., Tripathi, M. (2019). Pharmacotherapy of Trigeminal Neuralgia. In: Rath, G. (eds) Handbook of Trigeminal Neuralgia. Springer, Singapore. https://doi.org/10.1007/978-981-13-2333-1_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-2333-1_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2332-4
Online ISBN: 978-981-13-2333-1
eBook Packages: MedicineMedicine (R0)